Rather than IDO1, our immunohistochemical analyses of lung, heart, brain and blood cells from patients with fatal/severe COVID-19 showed extensive expression and activity of the otherwise rarely expressed IDO2. The gene discussed is IDO2; the disease is COVID-19.